Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals

NCT04403880 is registered in ClinicalTrials.gov with HIV Vaccine Trials Network as lead sponsor.

NCT NCT04403880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04403880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
Lead sponsor
HIV Vaccine Trials Network
Phase
Observational
Overall status
Completed
Start date
May 13, 2020
Completion date
April 21, 2022
Enrollment
760 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2